has been updated to include a new warning regarding the risk of Guillain-Barré syndrome (GBS) following vaccination. To assess the risk of GBS with these vaccines, the FDA conducted a ...
vaccines to include warnings and precautions about the risk for Guillain-Barré syndrome (GBS). For each vaccine, postmarketing observational studies suggest an increased risk of GBS during the 42 ...
BARRE — Perception and reality collided in the second-floor meeting room of Alumni Hall on Monday night when a public safety forum turned into the mother of all conversation starters. Where it goes ...
BARRE, Vt. (WCAX) - A week-long manhunt ended in a dramatic standoff Saturday night in Barre with police arresting a suspect who police say rammed his car into a local grocery store. The incident ...
According to the FDA, the benefits of vaccination with Abrysvo and Arexvy continue to outweigh the potential risks. To assess the risk of GBS with these vaccines, the FDA conducted a postmarketing ...
BARRE — Two people are facing assault charges after police say they attacked a woman at a home in the Granite City. Leah Deering, 57, of Barre, pleaded not guilty Monday in Washington County criminal ...
The FDA will require RSV vaccines to carry a warning about Guillain-Barré syndrome. Federal vaccine advisors expressed concern about a potential association between the shots and the rare disorder.
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The ...
Background: Little is known about the long term prognosis for patients the severe acute motor axonal neuropathy (AMAN) form of Guillain–Barré syndrome (GBS), unlike those with acute inflammatory ...
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo, prompting the regulator to require adjustments ...
ANX005 Phase 3 Population Was Matched 1:1 on Prespecified Criteria with Patients in International GBS Outcomes Study [IGOS] Matched Cohort Study Showed Early and Greater Benefits of ANX005 over ...
The council voted 4-3 on Monday to pledge the money to the Barre Area Development Corporation, which hopes to raise the full $1 million purchase price by June. The nonprofit plans to buy the ...